These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10800484)

  • 1. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease.
    Hank JA; Albertini MR; Sondel PM
    Cancer Chemother Biol Response Modif; 1999; 18():210-22. PubMed ID: 10800484
    [No Abstract]   [Full Text] [Related]  

  • 2. Site-specific 32P-labeling of cytokines, monoclonal antibodies, and other protein substrates for quantitative assays and therapeutic application.
    Clark WA; Izotova L; Philipova D; Wu W; Lin L; Pestka S
    Biotechniques; 2002 Oct; Suppl():76-8, 80-7. PubMed ID: 12395930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies and fusion proteins in medicine.
    Liossis SN; Tsokos GC
    J Allergy Clin Immunol; 2005 Oct; 116(4):721-9; quiz 730. PubMed ID: 16210042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic agents in psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Nov; 47(4):217-29; quiz 229-30. PubMed ID: 17034462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and monoclonal antibodies: an introduction of their current and future applications to cancer and other diseases.
    Borden E
    Med Sect Proc; 1992; ():51-62. PubMed ID: 1306563
    [No Abstract]   [Full Text] [Related]  

  • 9. How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
    Breitz HB
    J Nucl Med; 2000 Dec; 41(12):2011-4. PubMed ID: 11138686
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oncology 1999: advances in immunotherapy].
    Cerny T
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):21-4. PubMed ID: 10670041
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.
    Young PA; Morrison SL; Timmerman JM
    Semin Oncol; 2014 Oct; 41(5):623-36. PubMed ID: 25440607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapy.
    Schwartz MA; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1992; 13():156-74. PubMed ID: 1389908
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted monoclonal antibody-based treatment of hematological malignancies.
    Kaspers GJ
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):253-5. PubMed ID: 12820769
    [No Abstract]   [Full Text] [Related]  

  • 15. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1996; 16():168-88. PubMed ID: 8639382
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering antibodies for the clinic.
    Holliger P; Bohlen H
    Cancer Metastasis Rev; 1999; 18(4):411-9. PubMed ID: 10855784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
    Magdelaine-Beuzelin C; Kaas Q; Wehbi V; Ohresser M; Jefferis R; Lefranc MP; Watier H
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):210-25. PubMed ID: 17624800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.
    Zhang M; Zhang Z; Garmestani K; Schultz J; Axworthy DB; Goldman CK; Brechbiel MW; Carrasquillo JA; Waldmann TA
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1891-5. PubMed ID: 12569172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.